ITGBL1 and gastric cancer: Then, perifosine, an inhibitor of the AKT pathway, was used to demonstrate whether ITGBL1 inhibits FBLN2 expression in GC cells and promotes anoikis resistance and metastasis through the AKT signalling pathway.